CAS 444805-28-1
:Hexadecyloxypropyl-cidofovir
- Phosphonic acid, [[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, mono[3-(hexadecyloxy)propyl] ester
- Phosphonic acid, P-[[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, mono[3-(hexadecyloxy)propyl] ester
- CMX 001
- HDP-cidofovir
- Hexadecyloxypropyl-cidofovir
Brincidofovir
CAS:Formel:C27H52N3O7PReinheit:(HPLC) ≥ 98.0%Farbe und Form:White to off-white powderMolekulargewicht:561.69Brincidofovir
CAS:Brincidofovir (HDP-CDV) is an orally active, lipophilic form of cidofovir.Formel:C27H52N3O7PReinheit:98% - 99.62%Farbe und Form:SolidMolekulargewicht:561.69CMX 001
CAS:CMX 001 is an antiviral medication that is a prodrug of cidofovir, which is derived from nucleoside analogs with direct inhibition of viral DNA polymerase. This mechanism of action allows CMX 001 to effectively disrupt viral replication by integrating into viral DNA and halting its synthesis. Designed to target a broad range of DNA viruses, this drug offers a robust means of controlling viral infections.
Formel:C27H52N3O7PReinheit:Min. 98 Area-%Farbe und Form:PowderMolekulargewicht:561.69 g/molCMX 001 - Bio-X ™
CAS:Brincidofovir is a lipid prodrug of cidofovir which is used in the treatment of smallpox infections. It is an antiviral drug and inhibits viral replication by inhibiting viral DNA polymerase and viral RNA synthesis.
Formel:C27H52N3O7PReinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:561.69 g/molBrincidofovir
CAS:Kontrolliertes ProduktApplications Brincidofovir is an antiviral inhibitor, working against BK polymavirus replication in primary human urothelial cells. Cytostatic, cytotoxic agent.
References Tylden, G. et al.: Antimicrob. Agent. Chemother., 59, 3306 (2015); Cardile, A. et al.: Recent Patents Anti-Infect. Drug DIscov., 9, 97 (2014)Formel:C27H52N3O7PFarbe und Form:NeatMolekulargewicht:561.69





